United States - English - NLM (National Library of Medicine)

haemonetics corporation - citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anhydrous citric acid 4.2 mg in 1 ml - the haemonetics 250ml anticoagulant citrate phosphate double dextrose (cp2d) and 250ml additive solution formula 3 (as-3) nutrient solution are intended to be used only with automated apheresis devices for collecting human blood and blood components. the anticoagulant solution is metered by the apheresis machine into the collected whole blood. it is not to be infused directly into the donor. after the anticoagulant is used, the bag in which it was contained is discarded. when collecting plasma in the rbcp protocol, the plasma is collected into an empty plasma collection bag. one hundred milliliters (100ml) of as-3 is transferred into one rbc collection bag when using the rbcp protocol or 2 separate bags when using the 2rbc protocol. as-3 solution provides nutrients to keep the red blood cells viable for 42 days when refrigerated. cp2d is also indicated for the collection of ffp and pf24 plasma, collected and stored plasma collected using the 822, 822-2p and 822f-2p disposable sets may be frozen within 8 hours

United States - English - NLM (National Library of Medicine)

haemonetics corporation - citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok) - anhydrous citric acid 32.7 mg in 1 ml - for use with haemonetics apheresis devices rx only the haemonetics 250ml anticoagulant citrate phosphate double dextrose (cp2d) and 250ml additive solution formula 3 (as-3) nutrient solution are intended to be used only with automated apheresis devices for collecting human blood and blood components. the anticoagulant solution is metered by the apheresis machine into the collected whole blood. it is not to be infused directly into the donor. after the anticoagulant is used, the bag in which it was contained is discarded. when collecting plasma in the rbcp protocol, the plasma is collected into an empty plasma collection bag. one hundred milliliters (100ml) of as-3 is transferred into one rbc collection bag when using the rbcp protocol or 2 separate bags when using the

United States - English - NLM (National Library of Medicine)

haemonetics corporation - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37) - sodium chloride 900 mg in 100 ml - sodium chloride injection, usp is indicated as a source of water and electrolytes. 0.9% sodium chloride in hemodialysis procedures. none known safety and effectiveness of sodium chloride injection, usp in pediatric patients have not been established by adequate and well controlled trials; however, the use of sodium chloride solutions in the pediatric populations is referenced in the medical literature. the warnings, precautions and adverse reactions identified in the label copy should be observed in the pediatric population.  do not administer unless solution is clear and seal is intact.

United States - English - NLM (National Library of Medicine)

haemonetics corporation - anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) -

United States - English - NLM (National Library of Medicine)

haemonetics corporation - citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anhydrous citric acid 4.2 mg in 1 ml

United States - English - NLM (National Library of Medicine)

haemonetics corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anhydrous citric acid 40 mg in 1 ml

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - hematology - the haemonetics cell saver 5+ system and its related accessory devices are intended to be used for recovery of blood shed during or after an operation, or as the result of trauma, processing the blood by a centrifugation and washing procedure and pumping this processed red cell product to either a bag for gravity reinfusion into the patient or to the arterial line of an extracorporeal circuit for reinfusion into the patient. the cs5+ system should be considered for a procedure when it is anticipated that blood will be shed from a clean wound and retrieved at a rate permitting aspiration without undue hemolysis. the presence of any of the following criteria may be an indication for blood salvage: • anticipated blood loss is 15% or more of the patient’s estimated blood volume. • blood would ordinarily be crossmatched. • more than 10% of the patients undergoing the type of procedure require transfusion. • the mean transfusion rate for the type procedure exceeds one unit.

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - general hospital - rc1ve and rc1vae are indicated for the removal of leucocytes, platelets and microaggregates from a single unit of red cells or whole blood. rc2vae is indicated for the removal of leucocytes, platelets and microaggregates from up to two units of buffy coat depleted red cells.

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - general hospital - free-flow, low priming volume device which provides a 40 μm rated screen filter medium for the removal of potentially harmful microaggregates from stored blood, fresh blood, red cells, platelet and granulocyte concentrates, cryoprecipitates, plasma and plasma fractions and for filtration of viaspan (cold storage solution). the filter is also useful for reducing the incidence of febrile reactions and thrombocytopenia, following blood transfusion.

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - general hospital - indicated for the collection of 450 ml of blood and preparation of platelets and plasma with pre-storage leucocyte removal from red cells.